Steven S. Raman, MD, presented “Image-Guided Minimally-Invasive Whole Gland Treatment” during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer in October 2020.
How to cite: Raman, Steven S. “Image-Guided Minimally-Invasive Whole Gland Treatment.” October 2020. Accessed Apr 2024. https://dev.grandroundsinurology.com/image-guided-minimally-invasive-whole-gland-treatment/
Image-Guided Minimally-Invasive Whole Gland Treatment – Summary
Steven S. Raman, MD, Clinical Professor of Radiology and Director of Prostate MR Imaging and Interventions at the David Geffen School of Medicine of the University of California, Los Angeles, explains how magnetic resonance imaging (MRI) aids in prostate cancer staging, diagnosis, follow-up, treatment planning, and image-guided treatment. After reviewing relevant FDA guidelines, Dr. Raman outlines the MRI-guided transurethral ultrasound ablation (TULSA)-PRO® treatment planning and delivery process, noting the potential for real-time MR thermometry and feedback control. To further display benefits of the treatment, he reviews outcomes from the TACT trial. He then addresses potential next steps in prostate tissue ablation.
The Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer brings together key international opinion leaders of every clinical subspecialty involved in patient care. This event is an integral part of the AdMeTech Foundation’s Annual Summit, which was established in 2016 and become seminal in shaping the state of the art and future vision for precision care. The goal of this event is three-fold: 1) Educating the key stakeholders; 2) Supporting a sustained cross-disciplinary dialogue and consensus on the best emerging clinical practices and research priorities; and 3) Expediting clinical adoption of promising novel diagnostics and therapeutics. For more educational activities from this virtual event, visit our collection page.
